SORTINO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 761
EU - Europa 163
AS - Asia 70
AF - Africa 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.000
Nazione #
US - Stati Uniti d'America 761
IT - Italia 46
FI - Finlandia 33
CN - Cina 32
SG - Singapore 27
GB - Regno Unito 15
IE - Irlanda 15
RO - Romania 12
DE - Germania 9
SE - Svezia 9
RU - Federazione Russa 8
CH - Svizzera 5
BE - Belgio 4
TR - Turchia 4
HK - Hong Kong 3
UA - Ucraina 3
KR - Corea 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BR - Brasile 1
CI - Costa d'Avorio 1
CL - Cile 1
ES - Italia 1
FR - Francia 1
IN - India 1
LU - Lussemburgo 1
MA - Marocco 1
MC - Monaco 1
TW - Taiwan 1
Totale 1.000
Città #
Fairfield 153
Woodbridge 80
Ashburn 78
Seattle 61
Wilmington 52
Cambridge 51
Houston 50
Chandler 49
Ann Arbor 32
Des Moines 25
Singapore 24
Dublin 14
Santa Clara 13
Altamura 11
Medford 10
Nanjing 8
Palermo 8
Lawrence 7
Phoenix 7
Princeton 7
Brussels 4
Changsha 4
Helsinki 4
San Diego 4
Chicago 3
Dearborn 3
London 3
Nanchang 3
Shenyang 3
Zurich 3
Beijing 2
Boardman 2
Hong Kong 2
Izmir 2
Kilburn 2
Los Angeles 2
Orange 2
Saint Petersburg 2
San Paolo di Civitate 2
Seongnam 2
Tianjin 2
Abidjan 1
Central 1
Columbus 1
Custonaci 1
Forest City 1
Frankfurt am Main 1
Geneva 1
Guangzhou 1
Hefei 1
Huzhou 1
Islington 1
Jiaxing 1
Jinan 1
Kiev 1
Kunming 1
Ludwigshafen am Rhein 1
Luxembourg 1
Melbourne 1
Monaco 1
New Orleans 1
Pune 1
Rabat 1
Sanayi 1
Secaucus 1
São Paulo 1
Taipei 1
Taizhou 1
Tulsa 1
Wiesbaden 1
Zhongxin 1
Totale 826
Nome #
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 172
Monoclonal antibodies in gastrointestinal cancers 161
Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer? 152
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status 152
The role of targeted therapy for gastrointestinal tumors 150
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario 139
Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules 115
Totale 1.041
Categoria #
all - tutte 3.883
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.883


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020188 0 0 0 0 42 34 31 29 23 13 14 2
2020/2021119 14 4 8 6 3 2 13 12 12 20 14 11
2021/2022109 3 20 4 6 5 3 6 7 12 14 8 21
2022/2023158 25 33 4 15 14 25 21 5 4 1 8 3
2023/202454 1 11 5 6 5 2 3 10 2 2 0 7
2024/202556 2 25 21 7 1 0 0 0 0 0 0 0
Totale 1.041